Middle East & Africa Balloon Aortic Valvuloplasty Market

The Middle East & Africa balloon aortic valvuloplasty market was valued at US$ 9.99 million in 2023 and is expected to reach US$ 13.63 million by 2031; it is estimated to register a CAGR of 4.0% from 2023 to 2031.

Advancements in Aortic Valve Replacement Technologies Boost Middle East & Africa Balloon Aortic Valvuloplasty Market

Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical intervention. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. TAVI is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Additionally, developments in design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and lowered the risk of complications. For instance, in January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions. Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.

Middle East & Africa Balloon Aortic Valvuloplasty Market Overview

The increasing geriatric population, growing initiatives to create awareness about modern healthcare products, and efforts of organizations to offer advanced services to the population are the factors contributing to the balloon aortic valvuloplasty market growth in the Middle East & Africa.

As per the article "UAE Elevates Discussions on Healthy Ageing," published in June 2022, 1% of the UAE population was aged 60 and above in 2016. This figure is projected to reach 16% (2 million people) by 2050. In addition, as per the "Rights and Wellbeing of Older Persons in Saudi Arabia" report, the number of people aged 60 or more is predicted to increase five-fold during 2020-2050, rising from 2 million (5.9% of the total population) to 10.5 million (23.7% of the population). Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. As per the Statistics South Africa data, the country's estimated population included more than 5 million people aged 60 or above in 2022, representing 9.2% of the total South African population. In 2022, the elderly population of Iran totaled 9.2 million, representing 7.10% of the country's population. It is estimated that about 14% of Iran's population will become elderly by 2032, per the "Iran on the verge of aging crisis" article. As aged people are more susceptible to aortic stenosis, the growing geriatric population fuels the market for balloon aortic valvuloplasty.

In 2020, the Charlotte Maxeke Johannesburg Academic Hospital's Cardiology team performed the first TAVI procedure in the Gauteng Health public sector. The introduction of this service at the facility aids in mitigating the long waiting list for cardiac surgery combined with the poor outcomes of open-heart surgery in patients who pose a high risk. The first TAVI procedure in the world was performed in 2002, and seven years later, it was performed in South Africa. Since then, more than 2,000 South Africans have undergone TAVI; a vast majority of which is performed in the private sector. Valve disease continues to be prevalent in the UAE. According to a new study commissioned by Cleveland Clinic Abu Dhabi, an integral part of Mubadala Health, more than half of the country's residents have been affected by heart disease. In addition, the presence of cutting-edge technology and advanced healthcare facilities has introduced advanced treatment procedures in the region with better outcomes, which is likely to support the market growth. For instance, as per Khaleej times, in 2021, the Cleveland Clinic Abu Dhabi, UAE, performed transcatheter valve replacement for tricuspid valve regurgitation. Cleveland Clinic Abu Dhabi performs more than two-thirds of all heart disease cases in the UAE, with outcomes that are on par with those of the best programs in the world. The Department of Health - Abu Dhabi recently designated Cleveland Clinic Abu Dhabi as a Centre of Excellence for adult cardiac surgery to provide high-quality integrated cardiac surgery and structural heart disease interventions. Thus, the growing need for the treatment of heart diseases and the presence of advanced facilities propel the growth of the market in the region.

Middle East & Africa Balloon Aortic Valvuloplasty Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Balloon Aortic Valvuloplasty Strategic Insights

Strategic insights for the Middle East & Africa Balloon Aortic Valvuloplasty provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Balloon Aortic Valvuloplasty Report Scope

Middle East & Africa Balloon Aortic Valvuloplasty Regional Insights

The geographic scope of the Middle East & Africa Balloon Aortic Valvuloplasty refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Balloon Aortic Valvuloplasty Market Segmentation

The Middle East & Africa balloon aortic valvuloplasty market is categorized into product type and country.

Based on product type, the Middle East & Africa balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held the largest market share in 2023.

By country, the Middle East & Africa balloon aortic valvuloplasty market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa balloon aortic valvuloplasty market share in 2023.

B Braun SE; TT Medical, Inc.; Balton; Becton Dickinson and Co; Edwards Lifesciences Corp; Simeks are some of the leading companies operating in the Middle East & Africa balloon aortic valvuloplasty market.